JPS535369B2 - - Google Patents

Info

Publication number
JPS535369B2
JPS535369B2 JP4078073A JP4078073A JPS535369B2 JP S535369 B2 JPS535369 B2 JP S535369B2 JP 4078073 A JP4078073 A JP 4078073A JP 4078073 A JP4078073 A JP 4078073A JP S535369 B2 JPS535369 B2 JP S535369B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4078073A
Other languages
Japanese (ja)
Other versions
JPS4913317A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4913317A publication Critical patent/JPS4913317A/ja
Publication of JPS535369B2 publication Critical patent/JPS535369B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP4078073A 1972-04-10 1973-04-10 Expired JPS535369B2 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1645172A GB1432563A (en) 1972-04-10 1972-04-10 Platinum- co-ordination compounds
GB2139072 1972-05-08

Publications (2)

Publication Number Publication Date
JPS4913317A JPS4913317A (en:Method) 1974-02-05
JPS535369B2 true JPS535369B2 (en:Method) 1978-02-27

Family

ID=26252050

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4078073A Expired JPS535369B2 (en:Method) 1972-04-10 1973-04-10

Country Status (7)

Country Link
US (1) US3904663A (en:Method)
JP (1) JPS535369B2 (en:Method)
DE (1) DE2318021A1 (en:Method)
FR (1) FR2182942B1 (en:Method)
GB (1) GB1432563A (en:Method)
NL (1) NL7304881A (en:Method)
SE (1) SE396755B (en:Method)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419340A (en) * 1969-03-24 1983-12-06 University Of Delaware Controlled release of anticancer agents from biodegradable polymers
GB1578323A (en) * 1976-02-26 1980-11-05 Rustenburg Platinum Mines Ltd Compositions containing platinum
GB1585103A (en) * 1976-04-06 1981-02-25 Rustenburg Platinum Mines Ltd Pharmaceutical compositions containing platinum compounds
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
US4151185A (en) * 1977-05-02 1979-04-24 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4278660A (en) * 1977-05-02 1981-07-14 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4137248A (en) * 1977-08-29 1979-01-30 The United States Of America As Represented By The Department Of Health, Education And Welfare Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
JPS5829957B2 (ja) * 1977-09-12 1983-06-25 喜徳 喜谷 新規な白金錯体
US4225529A (en) * 1977-10-19 1980-09-30 Johnson, Matthey & Co., Limited Compositions containing platinum
US4230631A (en) * 1977-10-19 1980-10-28 Johnson, Matthey & Co., Limited Platinum coordination compounds
DE2845371A1 (de) * 1977-10-19 1979-04-26 Johnson Matthey Co Ltd Platinkomplexverbindung, pharmazeutische stoffzusammensetzung mit einer solchen verbindung und deren anwendung
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
US4405757A (en) * 1979-09-14 1983-09-20 Howell Bobby A Macromolecular complexes of amidocarbonylic water-soluble polymers and square planar platinous and equivalent organometallics
US4578491A (en) * 1982-06-28 1986-03-25 Engelhard Corporation Bis(thiocyanato)palladium(II) complexes
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4560782A (en) * 1982-11-19 1985-12-24 Research Corporation Anti-tumor diplatinum coordination compounds
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
ZA843515B (en) * 1983-05-10 1985-01-30 Andrulis Res Corp Bis-platinum complexes as antitumor agents
US4544759A (en) * 1983-07-29 1985-10-01 American Cyanamid Company Platinum complexes of antitumor agents
US4588831A (en) * 1984-11-09 1986-05-13 Natec Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5843475A (en) 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
KR20020029130A (ko) * 1999-09-14 2002-04-17 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 용기 폐쇄 시스템
AU1608801A (en) 1999-11-15 2001-05-30 Parker Hughes Institute Diamino platinum (ii) antitumor complexes
US7566798B2 (en) * 2003-08-13 2009-07-28 University Of South Florida Platinum complexes and methods of use
US20050288365A1 (en) * 2004-01-06 2005-12-29 Heidi Kay Platinum complexes and methods for inhibiting tumor cell proliferation
CA2587779A1 (en) * 2004-11-10 2007-01-18 University Of South Florida Platinum complexes for targeted drug delivery
WO2007006019A1 (en) * 2005-07-06 2007-01-11 University Of South Florida Materials and methods for screening, diagnosis and prognosis of conditions associated with stat protein expression
EP2036550A4 (en) 2006-06-28 2009-07-15 Ihi Corp MEDICINAL PRODUCTS, MEDICAMENT INDUCTION DEVICE, MAGNETIC DETECTOR AND MEDICAMENT DESIGN METHOD
JP4774536B2 (ja) * 2006-11-06 2011-09-14 株式会社Ihi 磁性材料、磁性材料の誘導装置及び磁性材料の設計方法
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
WO2010058280A1 (ja) 2008-11-20 2010-05-27 株式会社Ihi 自己磁性金属サレン錯体化合物
EP2582847B1 (en) 2010-06-18 2016-10-26 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
EP2609216B1 (en) 2010-08-24 2016-06-01 Dana-Farber Cancer Institute, Inc. Methods for predicting anti-cancer response
EP3693473B1 (en) 2011-06-17 2025-02-19 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
CA2860312C (en) 2011-12-21 2022-07-12 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
DK2817630T3 (en) 2012-02-23 2018-10-08 Childrens Medical Center Methods for predicting an anti-cancer response
CA3126823C (en) 2012-06-07 2023-04-04 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
US20140363521A1 (en) 2013-04-05 2014-12-11 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
EP3080292B1 (en) 2013-12-09 2022-02-02 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
WO2016025958A1 (en) 2014-08-15 2016-02-18 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Also Published As

Publication number Publication date
NL7304881A (en:Method) 1973-10-12
FR2182942A1 (en:Method) 1973-12-14
US3904663A (en) 1975-09-09
GB1432563A (en) 1976-04-22
SE396755B (sv) 1977-10-03
DE2318021A1 (de) 1973-11-08
JPS4913317A (en:Method) 1974-02-05
FR2182942B1 (en:Method) 1976-10-22

Similar Documents

Publication Publication Date Title
US4140707B1 (en:Method)
FR2182942B1 (en:Method)
JPS4976609A (en:Method)
JPS48104414A (en:Method)
JPS4984191U (en:Method)
JPS4887059U (en:Method)
FR2206531B1 (en:Method)
JPS5323072Y2 (en:Method)
JPS5026521Y1 (en:Method)
CS169863B1 (en:Method)
JPS48111540U (en:Method)
CS154486B1 (en:Method)
CH4872A4 (en:Method)
CH572641A5 (en:Method)
CH560978A5 (en:Method)
CH561128A5 (en:Method)
CH561148A5 (en:Method)
CH559772A5 (en:Method)
BG20013A1 (en:Method)
CH562018A5 (en:Method)
CH559128A5 (en:Method)
CH571707A5 (en:Method)
CH1117273A4 (en:Method)
CH1117073A4 (en:Method)
BG20698A1 (en:Method)